Finance

Beta
Lists
002275:SHE
Guilin Sanjin Pharmaceutical Co., Ltd.
CNÂĄ13.07
+1.55%
(+0.20) 1D
Jun 5, 3:04:21 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002275...
Open
CNÂĄ12.91
High
CNÂĄ13.12
Low
CNÂĄ12.87
Mkt. cap
7.56B
Avg. vol.
2.16M
Volume
1.15M
Dividend
3.83%
Quarterly dividend
CNÂĄ0.13
Ex-dividend date
Jun 4, 2026
P/E ratio
16.96
52-wk high
CNÂĄ17.38
52-wk low
CNÂĄ12.83
EPS
CNÂĄ0.77
Shares outstanding
587.57M
No. of employees
3K
Open
CNÂĄ12.91
High
CNÂĄ13.12
Low
CNÂĄ12.87
Mkt. cap
7.56B
Avg. vol.
2.16M
Volume
1.15M
Dividend
3.83%
Quarterly dividend
CNÂĄ0.13
Ex-dividend date
Jun 4, 2026
P/E ratio
16.96
52-wk high
CNÂĄ17.38
52-wk low
CNÂĄ12.83
EPS
CNÂĄ0.77
Shares outstanding
587.57M
No. of employees
3K
News stories
From sources across the web
About Guilin Sanjin Pharmaceutical Co., Ltd.
CEO-
Employees2.56K
Founded1985
Headquarters-
SectorPharmaceutical industry
Websitesanjin.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
531.77M
464.04M
583.35M
525.12M
Cost of goods sold
138.43M
120.09M
146.29M
93.13M
Cost of revenue
138.43M
120.09M
146.29M
93.13M
Research and development expenses
22.53M
30.18M
68.98M
53.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
166.45M
193.59M
270.13M
185.28M
Operating expense
205.53M
231.97M
354.02M
284.20M
Total operating expenses
343.96M
352.07M
500.30M
377.33M
Operating income
187.81M
111.98M
83.04M
147.79M
Other non operating income
-6.35K
-1.66M
1.46M
-151.83K
EBT including unusual items
212.09M
127.69M
67.38M
152.08M
EBT excluding unusual items
194.44M
116.86M
74.31M
150.90M
Income tax expense
30.09M
29.29M
19.47M
27.73M
Effective tax rate
14.19%
22.94%
28.90%
18.23%
Other operating expenses
8.97M
6.24M
1.60M
1.07M
Net income
182.01M
98.40M
47.91M
124.36M
Net profit margin
34.23%
21.21%
8.21%
23.68%
Earnings per share
-
-
-
-
Interest and investment income
6.64M
8.43M
6.17M
4.23M
Interest expense
-
-1.89M
-16.71M
-971.70K
Net interest expenses
6.64M
6.53M
-10.54M
3.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
209.11M
134.72M
103.95M
168.69M
Gain or loss from assets sale
-1.86K
1.86K
-145.62K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer